<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01617720</url>
  </required_header>
  <id_info>
    <org_study_id>VC1-2</org_study_id>
    <nct_id>NCT01617720</nct_id>
  </id_info>
  <brief_title>MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)</brief_title>
  <acronym>MITRAFIT</acronym>
  <official_title>MITRAFIT Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Study is designed to observe the clinical outcomes of patients requiring mitral repair&#xD;
      that were treated with the CE certified Cardinal System.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>• Ability of the Cardinal ring to reduce mitral valve regurgitation</measure>
    <time_frame>30 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>• Percentage of patients in whom the size of the ring is adjusted</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>• Technical feasibility of adjustment.</measure>
    <time_frame>6 months</time_frame>
    <description>The ability of the surgeon to adjust the Cardinal ring when required, will be measured on a scale of 1-3 (1- successfull, 3- unsuccessful)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>• The occurrence of serious device related adverse events in all patients.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">45</enrollment>
  <condition>Mitral Regurgitation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are candidate for mitral valve repair, with our without concomitant&#xD;
        procedures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Patient is a candidate for mitral valve repair, with our without concomitant&#xD;
             procedures.&#xD;
&#xD;
          -  Subject is willing to give informed consent for collection of his/her clinical data.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe organic lesions with retracted chordae&#xD;
&#xD;
          -  Congenital malformations with lack of valvular tissue&#xD;
&#xD;
          -  Severe valvular calcifications&#xD;
&#xD;
          -  Evolving bacterial endocarditis&#xD;
&#xD;
          -  Known Sensitivity to Nickel or Chromium&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ottavio Alfieri, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital San Raffaele, Milan, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas Doll, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SANA Herzchirurgie Stuttgart , Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ehud Raanani, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrik Nataf, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bichat Hospital, Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Volkmar Falk, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zurich University, Zurich, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SANA Herzchirurgie</name>
      <address>
        <city>Stuttgart</city>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital San Rafaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Sündermann SH, Czesla M, Kempfert J, Walther T, Nataf P, Raanani E, Jacobs S, Alfieri O, Maisano F, Falk V. Results of mitral valve repair with an adjustable annuloplasty ring 2 years after implantation. Heart Vessels. 2017 Jul;32(7):843-849. doi: 10.1007/s00380-016-0934-7. Epub 2016 Dec 23.</citation>
    <PMID>28012074</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 7, 2012</study_first_submitted>
  <study_first_submitted_qc>June 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2012</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mitral</keyword>
  <keyword>valve</keyword>
  <keyword>annuloplasty</keyword>
  <keyword>mitral regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

